Drug Profile


Alternative Names: RGH 2981; RT 3003

Latest Information Update: 08 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter
  • Developer Gedeon Richter; Takata Seiyaku
  • Class Antithrombotics; Peripheral vasodilators
  • Mechanism of Action Alpha adrenergic receptor antagonists; Calcium channel antagonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial occlusive disorders; Peripheral vascular disorders; Thrombosis

Most Recent Events

  • 08 Nov 2006 Discontinued - Phase-II for Arterial occlusive disorders in Japan (unspecified route)
  • 08 Nov 2006 Discontinued - Phase-II for Peripheral vascular disorders in Japan (unspecified route)
  • 09 Mar 1998 Phase-II clinical trials for Arterial occlusive disorders in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top